HAEMODYNAMIC EFFECTS OF BETA-2-RECEPT0R STIMULATION IN CHILDREN

K. Lundell,K. Sabel,R. Olegård
DOI: https://doi.org/10.1203/00006450-198510000-00298
IF: 3.953
1985-10-01
Pediatric Research
Abstract:Terbutalin (Te) increases PaO2 in hypoxic newborns with respiratory disorders. The haemodynamic effects of Te have not been investigated in infants previously. The hypothesis that Te reduces pulmonary vasoconstriction and increases cardiac output was investigated in infants with symtomatic ventricular septal defect (VSD) and postoperative children (PO) with suspicion of persistent pulmonary hypertension.Methods: During diagnostic heart catheterization main pulmonary artery (MPA), left atrium and systemic artery (BP) pressures as well as pulmonary flow (Qp) by thermodilution technique were determined before and after the injection of 10 ug/kg Te in the right atrium. Pulmonary vascular resistance (Rp) was expressed in UM2 (mean pressure gradient over pulmonary vascular bed divided by Qp in L/min per M2BSA)Results: In the VSD group (n=21) all but one had pulmonary hypertension. After Te systolic and mean MPA pressure decreased slightly (p< <0,05). Qp increased (p<0,01). Heart rate increased markedly and stroke volume decreased. Mean Rp decreased (p<0,01). BP dropped at 2 min and was restituted at 5 min. In the PO group all 12 had pulmonary hypertension. After Te MPA systolic pressure increased slightly (p<0,05) while diastolic and mean pressures were unchanged. Qp increased (p< <0,01). Mean Rp fell after Te (p<0,02). BP dropped at 2 and 5 min and was back to initial level at 10 min. No complications of Te injection were detected.Conclusion: The betareceptor stimulator Terbutalin reduces pulmonary as well as systemic vascular resistance and increases cardiac output. The drug may have diagnstic and therapeutic usefulness in conditions with pulmonary vasoconstriction and low cardiac output in early life.
What problem does this paper attempt to address?